CARDOZA GEORGE 4
4 · SOPHiA GENETICS SA · Filed Mar 20, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CFO George Cardoza Sells 774 Shares
What Happened George Cardoza, Chief Financial Officer of SOPHiA GENETICS SA (SOPH), sold 774 shares in an open-market transaction on March 19, 2026. The weighted average price reported was $4.79 (range $4.72–$4.87), for total proceeds of about $3,705. The sale was made to satisfy tax withholding obligations from the vesting of restricted stock units on March 18, 2026 and was executed under a pre-established Rule 10b5-1 trading plan (non-discretionary).
Key Details
- Transaction date: 2026-03-19
- Shares sold: 774; weighted average price $4.79; price range $4.72–$4.87
- Proceeds: approximately $3,705
- Reason/footnote: sale to satisfy RSU tax withholding (F1); executed pursuant to a pre-established 10b5-1 plan and not a discretionary trade
- Pricing note (F2): reported price is a weighted average; the filer can provide per-trade prices on request
- Shares owned after transaction: not stated in the provided filing
- Filing timeliness: filed 2026-03-20 for a 2026-03-19 transaction (appears timely)
Context This was a routine tax-withholding sale tied to RSU vesting, not an open discretionary sell signal. Sales executed under 10b5-1 plans are pre-planned and often reflect administrative needs (taxes or liquidity) rather than a change in an insider’s view of the company. Purchases typically carry more weight for signaling insider confidence.
Insider Transaction Report
- Sale
Ordinary Shares
[F1][F2]2026-03-19$4.79/sh−774$3,705→ 184,858 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on March 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.72 to $4.87, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.